Thelansis

Global ⁠ Tourette Syndrome (TS) Epidemiology Insights Thelansis’s “Global ⁠ Tourette Syndrome (TS) Epidemiology Insights and Forecast Report (Top 32 Markets) – 2020 To 2040″ provides an analysis of disease burden, characterized by disease definition, kidney biopsy cases, prevalence, incidence, diagnosed cases, severity, comorbidities, and clinical manifestations. Potential patient flow dynamics in disease burden are driven by shifts in demographic indicators and their correlation with age and gender distribution over time. Changes in the reported cases and long-term survival of patients may depend on diet, lifestyle, comorbid conditions, and the availability of interventions or therapies for the 32 markets (North America, Europe, Middle East, Asia Pacific, Africa, South / Latin America) . Global ⁠ Tourette Syndrome (TS) Overview Tourette syndrome (TS) is a complex neurodevelopmental disorder clinically defined by the presence of multiple motor tics and at least one vocal (phonic) tic...

Global ⁠ Tourette Syndrome (TS) Epidemiology Insights Thelansis’s  “Global ⁠ Tourette Syndrome (TS) Epidemiology Insights and Forecast Report (Top 32 Markets) – 2020 To 2040 ″ provides an analysis of disease burden, characterized by disease definition, kidney biopsy cases, prevalence, incidence, diagnosed cases, severity, comorbidities, and clinical manifestations. Potential patient flow dynamics in disease burden are driven by shifts in demographic indicators and their correlation with age and gender distribution over time. Changes in the reported cases and long-term survival of patients may depend on diet, lifestyle, comorbid conditions, and the availability of interventions or therapies for the 32 markets (North America, Europe, Middle East, Asia Pacific, Africa, South / Latin America). Key business questions answered: 20-year historical and forecast data (2020–2040) Disease definition based on globally accepted and latest criteria (e.g., ICD-10 codes) Gra...